These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 13583443)

  • 21. THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE.
    ZILBER LA; BAJDAKOVA ZL; GARDASJAN AN; KONOVALOV NV; BUNINA TL; BARABADZE EM
    Bull World Health Organ; 1963; 29(4):457-81. PubMed ID: 14099673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of pyridoxine hydrochloride to prevent isoniazid toxicity.
    ROSS RR
    J Am Med Assoc; 1958 Sep; 168(3):273-5. PubMed ID: 13575154
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 24. Concurrent administration of pyridoxine and isoniazid.
    MCCUNE RM; TOMPSETT R; WASZ-HOCKERT O
    Am Rev Tuberc; 1956 Sep; 74(3):471-3. PubMed ID: 13354935
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems connected with combination therapy of pulmonary tuberculosis; bacteriological results of monotherapy with isoniazid & combination therapy with isoniazid & streptomycin].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1958; 119(4):371-5; discussion 375-88. PubMed ID: 13607372
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quantitative changes of neurotrophils in streptomycin and PAS therapy of pulmonary tuberculosis].
    GLEBOVICH OV
    Probl Tuberk; 1957; 35(3):58-62. PubMed ID: 13484931
    [No Abstract]   [Full Text] [Related]  

  • 27. [Continuous clinical & bacteriological studies on results of prolonged isoniazid & PAS therapy of pulmonary tuberculosis].
    HELWEG-LARSEN P; RASMUSSEN KN
    Nord Med; 1957 Sep; 58(38):1409-10. PubMed ID: 13484025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of caseo-cavernous tuberculosis in children with large doses of INH and small doses of PAS].
    STOJKOV N
    Tuberkuloza; 1962; 14():123-31. PubMed ID: 13984298
    [No Abstract]   [Full Text] [Related]  

  • 29. [USE OF VITAMIN B 6 THERAPY IN PULMONARY TUBERCULOSIS].
    ARTEMIEV NI
    Sov Med; 1964 Aug; 27():77-80. PubMed ID: 14239231
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin B6 and mental deficiency; the effects of large doses of B6 (pyridoxine) in phenylketonuria.
    McGEER EG; TISCHLER B
    Can J Biochem Physiol; 1959 Mar; 37(3):485-91. PubMed ID: 13638867
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of early cavitary pulmonary tuberculosis with combined streptomycin and PAS in intravenous perfusion, prednisone, neuroregulatory drugs and aerosols of bronchodilatatory and fibrinopyolytic drugs].
    BORSELLA C
    G Ital Della Tuberc; 1957; 11(4):225-33. PubMed ID: 13474411
    [No Abstract]   [Full Text] [Related]  

  • 32. [Personal impressions on the clinical efficacy of isoniazid administration by aerosol, orally or parenterally, and with or without streptomycin in the treatment of pulmonary tuberculosis].
    BASSI M; BONAVIA R
    Arch Med Interna; 1956; 8(5):111-22. PubMed ID: 13459631
    [No Abstract]   [Full Text] [Related]  

  • 33. [Idiopathic tremor; occasional remarkable effects of large doses of pyridoxine].
    BOUTTIER D; DEREUX J; HEBERT H; PIOT C; SIGWALD J
    Rev Neurol (Paris); 1956 Apr; 94(4):406-8. PubMed ID: 13390250
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with isoniazid-PAS in the treatment of cavernous and exsudative pulmonary tuberculoses in children and adolescents].
    MEYERHOFF WK
    Med Monatsschr; 1957 Aug; 11(8):523-5. PubMed ID: 13464423
    [No Abstract]   [Full Text] [Related]  

  • 35. [A molecular combination of isoniazid and PAS in therapy of tuberculosis].
    HAHN J
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):217-21. PubMed ID: 13602782
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood levels of paraaminosalicylic acid (PAS) in patients with pulmonary tuberculosis. II. Production and clinical use of the potassium salt of paraaminosalicylic acid (K-PAS)].
    OSINSKA K; KORKUCZANSKI A; WARESKA W
    Gruzlica (1926); 1958 Jun; 26(6):473-8. PubMed ID: 13562667
    [No Abstract]   [Full Text] [Related]  

  • 37. [Duration of results in chemotherapy of pulmonary tuberculosis, with special consideration of isoniazid].
    CHRISTENSEN O; HOLM S; RASMUSSEN KH
    Nord Med; 1957 Sep; 58(38):1403-5. PubMed ID: 13484022
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problem of treatment of pulmonary tuberculosis with stroke doses of isoniazid].
    SOSNOWSKI K
    Gruzlica (1926); 1957 Jul; 25(7):581-6. PubMed ID: 13501615
    [No Abstract]   [Full Text] [Related]  

  • 39. [Notes on streptomycin and isoniazid resistance in a group of 80 patients].
    CAZZANIGA G; VIGNATI P; LOPS M
    G Ital Della Tuberc; 1958; 12(4):225-9. PubMed ID: 13574584
    [No Abstract]   [Full Text] [Related]  

  • 40. [Isoniazid chemotherapy and chemoprophylaxis of tuberculosis].
    OMODEI-ZORINI A
    Riforma Med; 1958 Aug; 72(31):877-80. PubMed ID: 13579965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.